Preparation of magnetic polybutylcyanoacrylate nanospheres encapsulated with aclacinomycin A and its effect on gastric tumor
Open Access
- 1 January 2004
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 10 (14), 2010-2013
- https://doi.org/10.3748/wjg.v10.i14.2010
Abstract
AIM: To evaluate the effect of aclacinomycin A-loaded magnetic polybutylcyanoacrylate nanoparticles on gastric tumor growth in vivo and in vitro. METHODS: Magnetic polybutylcyanoacrylate (PBCA) nanospheres encapsulated with aclacinomycin A (MPNS-ACM) were prepared by interfacial polymerization. Particle size, shape and drug content were examined. Female BABL/c nude mice were implanted with MKN-45 gastric carcinoma tissues subcutaneously to establish human gastric carcinoma model. The mice were randomly divided into 5 groups of 6 each: ACM group (8 mg/kg bm); group of high dosage of MPNS-ACM (8 mg/kg bm); group of low dosage of MPNS-ACM (1.6 mg/kg bm); group of magnetic PBCA nanosphere (MPNS) and control group (normal saline). Magnets (2.5 T) were implanted into the tumor masses in all of the mice one day before the therapy. Above-mentioned drugs were administered intravenously to the mice of every group on the first day and sixth day. When the mice were sacrificed, tumor weight was measured, and the assay of granulocyte- macrophage colony forming-unit (CFU-GM) was performed on semi-solid culture. White blood cell, alanine aminotransferase and creatine were examined. 3-[4-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) was used to examine the viability of MKN-45 cells after incubation with different concentrations of ACM, MPNS and MPNS-ACM suspension respectively for 48 h. RESULTS: Content of ACM in MPNS-ACM was 12.0% and the average diameter of the particles was 210 nm. The inhibitory rates of ACM (8 mg/kg bm), high dosage of MPNS-ACM (8 mg/kg bm), low dosage of MPNS-ACM (1.6 mg/kg bm) and MPNS on human gastric carcinoma in nude mice were 22.63%, 52.55%, 30.66% and 10.22%, respectively. There was a significant decrease in the number of CFU-GM of bone marrow in ACM group compared with control group, whereas no obvious change was observed in that of the nanosphere groups. The values of 50% inhibition concentration (IC50) of ACM, MPNS and MPNS-ACM were 0.09, 97.78 and 1.07 μg/mL, respectively. CONCLUSION: The tumor inhibitory rate of MPNS-ACM was much higher than that of ACM under magnetic field and the inhibition on bone marrow was alleviated significantly compared with ACM group.Keywords
This publication has 25 references indexed in Scilit:
- Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applicationsAdvanced Drug Delivery Reviews, 2003
- [Enhanced activity of rifampicin loaded with polybutyl cyanoacrylate nanoparticles in relation to intracellularly localized bacteria].2003
- Preparation of magnetic polymeric particles via inverse microemulsion polymerization processJournal of Magnetism and Magnetic Materials, 2002
- Nanocapsule Technology: A ReviewCritical Reviews in Therapeutic Drug Carrier Systems, 2002
- Tamoxifen encapsulation within polyethylene glycol-coated nanospheres. A new antiestrogen formulationInternational Journal of Pharmaceutics, 2001
- Tissue Adhesives: A New Method of Wound RepairThe Nurse Practitioner, 1999
- Study on the anticarcinogenic effect and acute toxicity of liver-targeting mitoxantrone nanoparticlesWorld Journal of Gastroenterology, 1999
- Long-term stability of PBCA nanoparticle suspensions suggests clinical usefulnessInternational Journal of Pharmaceutics, 1997
- Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticlesInvestigational New Drugs, 1992
- Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: Total remission in Yoshida sarcoma-bearing ratsEuropean Journal of Cancer and Clinical Oncology, 1983